Maxcyte (Di) Share Price (MXCT)

The sector is out of favour and the bears/shorters are feasting. Personally, I'm gritting my teeth and bearing it. The way I see it the so-called "investor gurus" have been pumping up growth shares for years, justifying higher and higher multiples, but started to do a volte-face around October last year (it's interesting that financial newspapers were still promoting growth shares at the expense income shares early this year). These things move in cycles and I'm sure that the "gurus" will be back to promote growth shares in the not too distant future; the opportunity to keep the pump'n'dump gravy train on the road is just too great.

As regards MXCT, I see them as providing the shovels for the "genetic" gold rush to come and still take some comfort from the subscription in February 2021, before the NASDAQ listing (in hindisght the worst decision ever made). Their keystone investors are highly unlikely to consider any offer below their £7 subscription price and IMHO wouldn't currently settle for less than £10 per share.

I am surprised as you are.
It was good functioning share till covid!

“AIM volatility and lack of interest are a real turn off for IIs and deter PIs too. Doesn't make sense but a good time to buy and top up.”

It’s got nothing to do with AIM and everything to do with the dual NASDAQ listing. It’ll bottom when the XBI index does. At £100m enterprise value I’m not sure why a rival or bigger fish wouldn’t take it out?

Any ideas where the bottom comes in for these guys...surely we do not see sub 2?? Long and scaling in from time to time. So where do you think we can expect to see maximum pain here? Any notions? Thanks in advance.

Further drop today of 6% on only a small volume of sells (£50k) with a SP drop of 70% in last 9 months. Considering the company is well funded the drop is hard to fathom. Total cash, cash equivalents and short-term investments were $246.3 million as of March 31, 2022.
AIM volatility and lack of interest are a real turn off for IIs and deter PIs too. Doesn't make sense but a good time to buy and top up. Other bios are in a similar position but it is tough to take and must be a big blow to management as well.